HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Takashi Shingu Selected Research
Takashi Shingu Research Topics
Disease
11
Neoplasms (Cancer)
01/2021 - 01/2003
9
Glioma (Gliomas)
01/2022 - 01/2003
5
Glioblastoma (Glioblastoma Multiforme)
01/2023 - 05/2008
3
Brain Neoplasms (Brain Tumor)
02/2016 - 02/2011
2
Demyelinating Diseases (Demyelinating Disease)
01/2021 - 01/2020
2
Carcinogenesis
04/2015 - 05/2009
2
Leukemia
05/2009 - 03/2009
2
Astrocytoma (Pilocytic Astrocytoma)
05/2007 - 05/2002
1
Cataract (Cataracts)
01/2021
1
Chronic Progressive Multiple Sclerosis
01/2020
1
T-Cell Lymphoma (Lymphoma, T Cell)
04/2015
1
Genomic Instability
04/2015
1
Residual Neoplasm
09/2011
1
Hypoxia (Hypoxemia)
09/2011
1
Primitive Neuroectodermal Tumors (PNET)
10/2005
Drug/Important Bio-Agent (IBA)
2
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
02/2016 - 01/2003
2
Platinum
IBA
02/2011 - 12/2010
2
BBR3610
IBA
02/2011 - 12/2010
2
Platinum Compounds (Compounds, Platinum)
IBA
02/2011 - 12/2010
2
Cisplatin (Platino)
FDA Link
Generic
02/2011 - 07/2003
2
Imatinib Mesylate (Gleevec)
FDA Link
05/2009 - 03/2009
2
2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
IBA
07/2003 - 01/2003
1
Nestin
IBA
01/2023
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2022
1
Protein Aggregates
IBA
01/2021
1
Cholesterol
IBA
01/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
Lipids
IBA
01/2020
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
02/2016
1
Catenins
IBA
02/2016
1
Sorafenib (BAY 43-9006)
FDA Link
02/2016
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
02/2016
1
Sepharose (Agarose)
IBA
02/2016
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
02/2016
1
afimoxifene (hydroxytamoxifen)
IBA
04/2015
1
Estrogen Receptors
IBA
04/2015
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
04/2015
1
Oxygen (Dioxygen)
IBA
09/2011
1
Succinate Dehydrogenase (Fumarate Reductase)
IBA
09/2011
1
Antineoplastic Agents (Antineoplastics)
IBA
09/2011
1
Adenosine Triphosphate (ATP)
IBA
09/2011
1
Cytotoxins (Cytolysins)
IBA
02/2011
1
PX-866
IBA
02/2011
1
Spermine
IBA
12/2010
1
Tyrosine (L-Tyrosine)
FDA Link
05/2009
1
Phosphotransferases (Kinase)
IBA
05/2009
1
Tyrosine Kinase Inhibitors
IBA
03/2009
1
Protein Isoforms (Isoforms)
IBA
05/2008
1
Complementary DNA (cDNA)
IBA
05/2008
1
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
05/2008
1
Vincristine (Oncovin)
FDA Link
Generic
07/2003
1
Paclitaxel (Taxol)
FDA Link
Generic
07/2003
1
Carmustine (FIVB)
FDA Link
07/2003
1
Caspases
IBA
07/2003
1
Alkylating Agents
IBA
07/2003
1
A-Form DNA (A-DNA)
IBA
07/2003
1
Topoisomerase II Inhibitors
IBA
07/2003
1
Etoposide (VP 16)
FDA Link
Generic
07/2003
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
07/2003
1
Tensins
IBA
01/2003
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
01/2003
1
Deuterium Oxide (Heavy Water)
IBA
05/2002
Therapy/Procedure
9
Therapeutics
01/2023 - 01/2003
5
Drug Therapy (Chemotherapy)
01/2016 - 07/2003
2
Radiotherapy
05/2007 - 10/2005
1
Immunotherapy
01/2023
1
Aftercare (After-Treatment)
09/2011